Bleiberg H - Search Results

1

Dose-finding study of tropisetron in cisplatin-induced nausea and vomiting.

Van Belle SJ, Stamatakis L, Bleiberg H, Cocquyt VF, Michel J, de Bruijn KM. Van Belle SJ, et al. Among authors: bleiberg h. Ann Oncol. 1994 Nov;5(9):821-5. doi: 10.1093/oxfordjournals.annonc.a059011. Ann Oncol. 1994. PMID: 7848884 Free article. Clinical Trial.

2

Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban Group.

Van Belle SJ, Cocquyt VF, Bleiberg H, Canon JL, Buyse M, Hulstaert F, De Witte M, De Keyser P, Westelinck K. Van Belle SJ, et al. Among authors: bleiberg h. Anticancer Drugs. 1995 Feb;6 Suppl 1:22-30. Anticancer Drugs. 1995. PMID: 7749166 Clinical Trial.

3

Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting.

Hulstaert F, Van Belle S, Bleiberg H, Canon JL, Dewitte M, Buyse M, De Keyser P, Westelinck KJ. Hulstaert F, et al. Among authors: bleiberg h. J Clin Oncol. 1994 Nov;12(11):2439-46. doi: 10.1200/JCO.1994.12.11.2439. J Clin Oncol. 1994. PMID: 7964961 Clinical Trial.

4

Compassionate use of tropisetron in patients at high risk of severe emesis.

Bleiberg H, Van Belle S, Paridaens R, De Wasch G, Dirix LY, Tjean M. Bleiberg H, et al. Ann Oncol. 1993;4 Suppl 3:43-5. doi: 10.1093/annonc/4.suppl_3.s43. Ann Oncol. 1993. PMID: 8364000

5

Compassionate use of a 5-HT3-receptor antagonist, tropisetron, in patients refractory to standard antiemetic treatment.

Bleiberg H, Van Belle S, Paridaens R, De Wasch G, Dirix LY, Tjean M. Bleiberg H, et al. Drugs. 1992;43 Suppl 3:27-32. doi: 10.2165/00003495-199200433-00007. Drugs. 1992. PMID: 1380430

6

Adjuvant radiotherapy and chemotherapy in resectable gastric cancer. A randomized trial of the gastro-intestinal tract cancer cooperative group of the EORTC.

Bleiberg H, Goffin JC, Dalesio O, Buyse M, Pector JC, Gignoux M, Roussel A, Samana G, Michel J, Gerard A, et al. Bleiberg H, et al. Eur J Surg Oncol. 1989 Dec;15(6):535-43. Eur J Surg Oncol. 1989. PMID: 2689236 Clinical Trial.

7

Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study.

Van Cutsem E, Dirix L, Van Laethem JL, Van Belle S, Borner M, Gonzalez Baron M, Roth A, Morant R, Joosens E, Gruia G, Sibaud D, Bleiberg H. Van Cutsem E, et al. Among authors: bleiberg h. Br J Cancer. 2005 Mar 28;92(6):1055-62. doi: 10.1038/sj.bjc.6602462. Br J Cancer. 2005. PMID: 15756271 Free PMC article. Clinical Trial.

8

A phase I trial of a new antiemetic drug--clebopride malate--in cisplatin-treated patients.

Bleiberg H, Piccart M, Lips S, Panzer JM, N'Koua Mbon JB. Bleiberg H, et al. Ann Oncol. 1992 Feb;3(2):141-3. doi: 10.1093/oxfordjournals.annonc.a058130. Ann Oncol. 1992. PMID: 1606084 Free article. Clinical Trial.

9

Tropisetron in the prevention of acute and delayed nausea and vomiting over six courses of emetogenic chemotherapy.

Bleiberg H, Hulstaert F, Buyse M, De Keyser P. Bleiberg H, et al. Anticancer Drugs. 1998 Oct;9(9):773-7. doi: 10.1097/00001813-199810000-00005. Anticancer Drugs. 1998. PMID: 9840722 Clinical Trial.

10

Phase II trial with chlorozotocin in advanced colorectal cancer.

Bleiberg H, Rozencweig M, Michel J, Clavel M, Longeval E, Feremans W, Bondue H, Lardinois J, Crespeigne N, Kenis Y. Bleiberg H, et al. Eur J Cancer Clin Oncol. 1981 Aug;17(8):863-6. doi: 10.1016/0014-2964(81)90306-6. Eur J Cancer Clin Oncol. 1981. PMID: 6459936 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters